• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Tuberculosis Pipeline Highlights - 2014 Update Product Image

Tuberculosis Pipeline Highlights - 2014 Update

  • Published: May 2014
  • Fore Pharma

The latest report Tuberculosis Pipeline Highlights – 2014 Update, provides most up-to-date information on key pipeline molecules in the global Tuberculosis market. It covers emerging therapies for Tuberculosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Tuberculosis pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Tuberculosis pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Tuberculosis pipeline molecules by the Originator Company.

Short-term Launch Highlights:
Find READ MORE >

1. Tuberculosis Pipeline by Stages
2. Tuberculosis Pipeline by Drug Class
3. Tuberculosis Pipeline by Company
4. Tuberculosis Phase 3 Clinical Trial Insights
5. Tuberculosis Phase 2 Clinical Trial Insights
6. Tuberculosis Phase 1 Clinical Trial Insights
7. Tuberculosis Preclinical Research Insights
8. Tuberculosis Discovery Stage Insights
9. Appendix
10. Research Methodology
Table 1: Tuberculosis Phase 3 Clinical Trials, 2014
Table 2: Tuberculosis Phase 2 Clinical Trials, 2014
Table 3: Tuberculosis Phase 1 Clinical Trials, 2014
Table 4: Tuberculosis Preclinical Research, 2014
Table 5: Tuberculosis Discovery Stage, 2014
Figure 1: Tuberculosis Pipeline Molecules by Clinical Trials Stage, 2014
Figure 2: Tuberculosis Pipeline Molecules by Drug Class, 2014
Figure 3: Tuberculosis Pipeline Molecules by Company, 2014
Figure 4: Tuberculosis Phase 3 Clinical Trial Highlights, 2014
Figure 5: Tuberculosis Phase 2 Clinical Trial Highlights, 2014
Figure 6: Tuberculosis Phase 1 Clinical Trial Highlights, 2014
Figure 7: Tuberculosis Preclinical Research Highlights, 2014
Figure 8: Tuberculosis Discovery Stage Highlights, 2014

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos